Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study
Rodolfo Chicas-Sett, Juan Zafra, Delvys Rodríguez‐Abreu, Juan Castilla-Martinez, Gretel Benítez, Bárbara Salas, Samuel Hernández, M. Lloret, Juan Luis Onieva, Isabel Barragán, Pedro C. Lara
Topics & Concepts
MedicineSABR volatility modelNivolumabInternal medicineOncologyConcomitantLung cancerMelanomaPembrolizumabAbscopal effectCancerCancer researchImmunotherapyVolatility (finance)Financial economicsEconomicsStochastic volatilityCancer Immunotherapy and BiomarkersMelanoma and MAPK PathwaysPeptidase Inhibition and Analysis